Abstract |
Neuronal nitric oxide synthase (nNOS) inhibition is a promising strategy to treat neurodegenerative disorders, but the development of nNOS inhibitors is often hindered by poor pharmacokinetics. We previously developed a class of membrane-permeable 2-aminoquinoline inhibitors and later rearranged the scaffold to decrease off-target binding. However, the resulting compounds had decreased permeability, low human nNOS activity, and low selectivity versus human eNOS. In this study, 5-substituted phenyl ether-linked aminoquinolines and derivatives were synthesized and assayed against purified NOS isoforms. 5-Cyano compounds are especially potent and selective rat and human nNOS inhibitors. Activity and selectivity are mediated by the binding of the cyano group to a new auxiliary pocket in nNOS. Potency was enhanced by methylation of the quinoline and by introduction of simple chiral moieties, resulting in a combination of hydrophobic and auxiliary pocket effects that yielded high (∼500-fold) n/e selectivity. Importantly, the Caco-2 assay also revealed improved membrane permeability over previous compounds.
|
Authors | Maris A Cinelli, Huiying Li, Georges Chreifi, Thomas L Poulos, Richard B Silverman |
Journal | Journal of medicinal chemistry
(J Med Chem)
Vol. 60
Issue 9
Pg. 3958-3978
(05 11 2017)
ISSN: 1520-4804 [Electronic] United States |
PMID | 28422508
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
|
Chemical References |
- Aminoquinolines
- Enzyme Inhibitors
- Nitriles
- Nitric Oxide Synthase Type I
|
Topics |
- Aminoquinolines
(pharmacology)
- Animals
- Drug Discovery
- Enzyme Inhibitors
(chemistry, pharmacology)
- Humans
- Nitric Oxide Synthase Type I
(antagonists & inhibitors, chemistry)
- Nitriles
(chemistry)
- Rats
|